JP2008501642A5 - - Google Patents

Download PDF

Info

Publication number
JP2008501642A5
JP2008501642A5 JP2007509950A JP2007509950A JP2008501642A5 JP 2008501642 A5 JP2008501642 A5 JP 2008501642A5 JP 2007509950 A JP2007509950 A JP 2007509950A JP 2007509950 A JP2007509950 A JP 2007509950A JP 2008501642 A5 JP2008501642 A5 JP 2008501642A5
Authority
JP
Japan
Prior art keywords
peptide
substantially pure
seq
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007509950A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008501642A (ja
JP4689664B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2005/004419 external-priority patent/WO2005105832A2/en
Publication of JP2008501642A publication Critical patent/JP2008501642A/ja
Publication of JP2008501642A5 publication Critical patent/JP2008501642A5/ja
Application granted granted Critical
Publication of JP4689664B2 publication Critical patent/JP4689664B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007509950A 2004-04-28 2005-04-25 生物学的に活性なペプチドvapeehptllteaplnpk誘導体 Expired - Fee Related JP4689664B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56645504P 2004-04-28 2004-04-28
US60/566,455 2004-04-28
PCT/EP2005/004419 WO2005105832A2 (en) 2004-04-28 2005-04-25 Biologically active peptide vapeehptllteaplnpk derivatives

Publications (3)

Publication Number Publication Date
JP2008501642A JP2008501642A (ja) 2008-01-24
JP2008501642A5 true JP2008501642A5 (cg-RX-API-DMAC10.html) 2009-01-29
JP4689664B2 JP4689664B2 (ja) 2011-05-25

Family

ID=34967983

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007509950A Expired - Fee Related JP4689664B2 (ja) 2004-04-28 2005-04-25 生物学的に活性なペプチドvapeehptllteaplnpk誘導体

Country Status (17)

Country Link
US (1) US7718764B2 (cg-RX-API-DMAC10.html)
EP (2) EP2058328B1 (cg-RX-API-DMAC10.html)
JP (1) JP4689664B2 (cg-RX-API-DMAC10.html)
KR (1) KR101323771B1 (cg-RX-API-DMAC10.html)
CN (1) CN1976947B (cg-RX-API-DMAC10.html)
AT (1) ATE505483T1 (cg-RX-API-DMAC10.html)
AU (1) AU2005238173B2 (cg-RX-API-DMAC10.html)
CA (1) CA2564179C (cg-RX-API-DMAC10.html)
DE (1) DE602005027502D1 (cg-RX-API-DMAC10.html)
DK (1) DK2058328T3 (cg-RX-API-DMAC10.html)
ES (1) ES2365084T3 (cg-RX-API-DMAC10.html)
NZ (1) NZ551595A (cg-RX-API-DMAC10.html)
PT (1) PT2058328E (cg-RX-API-DMAC10.html)
RU (1) RU2377249C2 (cg-RX-API-DMAC10.html)
TW (1) TWI353252B (cg-RX-API-DMAC10.html)
WO (1) WO2005105832A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA200608865B (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018105550A1 (ja) * 2016-12-05 2018-06-14 大塚製薬株式会社 筋萎縮抑制組成物
EP4069714A4 (en) * 2019-12-06 2024-02-21 Cooke Aquaculture Inc. PEPTIDES FOR GLUCOSE REGULATION
CN112812171B (zh) * 2021-01-22 2022-04-08 浙江辉肽生命健康科技有限公司 具有氨基酸结构vvrkplnkegkkp的生物活性肽及其制备方法和应用
US12605349B2 (en) 2024-09-05 2026-04-21 Orbus Therapeutics, Inc. Methods of treating grade 3 astrocytoma

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242821A (en) 1989-07-10 1993-09-07 Valio, Finnish Co-Operative Dairies' Association Lactococcus promoter and signal sequences for expression in bacteria
IT1231156B (it) 1989-07-19 1991-11-19 Eniricerche Spa Espressione e secrezione di interleuchina 1 beta umana matura in bacillus subtilis e mezzi e metodi per il suo ottenimento.
WO1994029450A2 (en) 1993-06-15 1994-12-22 E.I. Du Pont De Nemours And Company Novel, recombinantly produced spider silk analogs
JP3286420B2 (ja) 1993-09-28 2002-05-27 株式会社ユニシアジェックス 内燃機関の吸排気弁駆動制御装置
AU2631695A (en) 1994-06-17 1996-01-15 Nederlandse Organisatie Voor Toegepast- Natuurwetenschappelijk Onderzoek Tno Method for introduction of genetic material into microorganisms and transformants obtained therewith
US6184208B1 (en) 1994-06-29 2001-02-06 Immunotech Developments Inc. Peptide, a method for its preparation and a pharmaceutical composition containing the peptide
IL115199A (en) 1995-09-07 2005-05-17 Opperbas Holding Bv Composition comprising a polynucleic acid molecule in a liposome and method using said composition
EP0867450B1 (en) 1995-10-24 2004-08-11 Juridical Foundation, The Chemo-Sero-Therapeutic Research Institute TFPI-related Peptides which inhibit growth of smooth muscle cells
GB9710762D0 (en) * 1997-05-23 1997-07-23 Cancer Res Inst Royal Binding complexes
EP1015612B1 (en) 1997-05-27 2005-01-26 Hanil Synthetic Fiber Co., Ltd. Process for preparing recombinant proteins using highly efficient expression vector from saccharomyces cerevisiae
KR19990024297A (ko) 1997-08-07 1999-04-06 오종석 인체 구강내 치태형성을 억제하는 신규한 유산균
US6100388A (en) 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
US6562958B1 (en) * 1998-06-09 2003-05-13 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Acinetobacter baumannii for diagnostics and therapeutics
US6245427B1 (en) 1998-07-06 2001-06-12 DüZGüNES NEJAT Non-ligand polypeptide and liposome complexes as intracellular delivery vehicles
RU2172322C1 (ru) * 1999-12-27 2001-08-20 Энтофарм Ко., Лтд. Аллофероны-иммуномодулирующие пептиды
WO2002068601A2 (en) * 2001-02-28 2002-09-06 Skubitz Keith M Small peptides capable of modulating the function of cd66 (ceacam) family members
CN1213062C (zh) 2001-07-13 2005-08-03 一泰医药研究(深圳)有限公司 序列号13的生物活性肽
DE10133576A1 (de) * 2001-07-13 2003-01-30 Martin Klingmueller Verwendung von physiologisch aktiven Oligopeptiden zur Stabilisierung des Immunsystems
SG185137A1 (en) * 2001-07-13 2012-11-29 Cms Peptides Patent Holding Company Ltd Biologically active peptides
JPWO2004055045A1 (ja) * 2002-12-16 2006-04-20 株式会社シーエーエフラボラトリーズ サルモネラ抗原処方物、それを使用した抗体検査キット及びサブユニットワクチン
AU2003285258A1 (en) * 2002-12-18 2004-07-09 Pepharm R & D Limited Biologically active peptide conjugates

Similar Documents

Publication Publication Date Title
CN107997187A (zh) 具有改善皮肤弹性和延缓皱纹生成功能组合物及其应用
CN108078958A (zh) 一种抗肿瘤多肽纳米药物及其制备方法和应用
CN102526698A (zh) 虫草多肽氨基酸营养液
CN108892710A (zh) 龙须菜降压肽提取物和龙须菜降压肽及其应用
CN104610240A (zh) 双环醇-肌肽缀合物及其制备方法与应用
CN107582691A (zh) 复方黄柏液涂剂漱口凝胶
CN101773625A (zh) 一种抗癌药及其制备方法和应用
JP2010235544A (ja) 免疫活性化剤および飲食品
CA2530611A1 (en) Biologically active peptide comprising tyrosyl-seryl-valine (ysv)
EP4157284A1 (fr) Utilisation de nmn pour reduire l'immunodepression et l'immunosenescence
RU2006137699A (ru) Биологически активные производные пептида vapeehptllteaplnpk
CN101028098A (zh) 含有骨胶原肽的食品组合物
CN1528767A (zh) 一种抗癌镇痛的中药钩吻总生物碱和含它的药物组合物及其制备方法
CN101921820B (zh) 具有活性重组肿瘤特异性凋亡因子的制备方法及其制品的应用
CN108339116B (zh) 壬二酸的应用、含有壬二酸的佐剂和疫苗剂
CN114887052A (zh) 一种辅助治疗心血管疾病的蒸汽设备多维素及其制备方法和应用
JP6987271B2 (ja) 新規キノカルコン化合物、及びがん又は炎症を治療するためのその用途
CN101875688B (zh) 重组肿瘤特异性凋亡因子制备方法中的叶酸化修饰步骤及其制品的应用
CN1257183C (zh) 一种文蛤提取物及其制备方法与应用
CN106749461B (zh) 可自主装形成纳米微粒的维生素b12衍生物及制备方法与应用
CN106581645B (zh) 载有药物的维生素b12衍生物自组装纳米微粒及制备方法与应用
CN120754266A (zh) 一种基于分子对接技术筛选的药食同源活性成分-小分子肽-纳米硒协同抗衰老组合物
CN1129452C (zh) 表皮生长因子口含片
CN1290543C (zh) 一种医药保健品
CN1745627A (zh) 鸵鸟血及其相关制品的活性功能